Keyphrases
Atrial Fibrillation
100%
Anticoagulants
100%
Dutch
42%
Clinical Practice
28%
Baseline Characteristics
28%
Anticoagulation
28%
Vitamin K Antagonists
28%
Oral Anticoagulants
28%
Patient Registry
14%
Netherlands
14%
High Risk
14%
Treatment Options
14%
New Drugs
14%
International Normalized Ratio
14%
Health Systems
14%
Associated Risk
14%
Bleeding
14%
Stroke Risk
14%
Vitamin K Antagonist Therapy
14%
Oral Anticoagulation
14%
Treatment Pathways
14%
Therapy Persistence
14%
Therapy Compliance
14%
Enhanced Awareness
14%
Over 45
14%
INIS
patients
100%
anticoagulants
100%
therapy
60%
risks
60%
vitamin k
60%
drugs
20%
compliance
20%
tracks
20%
netherlands
20%
fluctuations
20%
Nursing and Health Professions
Atrial Fibrillation
100%
Anticoagulant Agent
100%
Antivitamin K
42%
Anticoagulation
42%
Physician
28%
Clinical Practice
28%
Cerebrovascular Accident
14%
Healthcare System
14%
Patient Compliance
14%
Bleeding
14%
Thromboembolism
14%
International Normalized Ratio
14%
Medicine and Dentistry
Atrial Fibrillation
100%
Antithrombotic
100%
Vitamin K Antagonist
42%
Anticoagulation
42%
Awareness
14%
Patient Registry
14%
Apoplexy
14%
Bleeding
14%
Patient Compliance
14%
Thromboembolism
14%